FDA Approved: BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Brimonidine tartrate ophthalmic solution 0.15% from Alembic Pharmaceuticals as an Original Application (ANDA) for lowering intraocular pressure in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Brimonidine Tartrate Ophthalmic Solution 0.15% (brimonidine tartrate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% (BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%)